期刊文献+

预先注射帕瑞昔布对不同剂量瑞芬太尼麻醉后痛觉过敏的影响 被引量:6

Influence of pretreated parecoxib on hyperalgesia after anesthesia by different doses of remifentanil
原文传递
导出
摘要 目的研究预先注射帕瑞昔布预防不同剂量瑞芬太尼麻醉后痛觉过敏的临床疗效。方法全身麻醉下行开腹子宫切除术患者分为2组(均n=20):小剂量瑞芬太尼组(S组)和大剂量瑞芬太尼组(L组)。2组均于麻醉诱导前30 min由静脉给予帕瑞昔布40 mg,S组和L组分别以血浆靶浓度2μg.L-1和4μg.L-1靶控输注瑞芬太尼,然后靶控输注丙泊酚(血浆靶浓度4 mg.L-1)行麻醉诱导和维持。患者在麻醉恢复室(PACU)应用视觉模拟评分法(VAS)进行疼痛评分,若VAS评分≥4分,静脉注射吗啡2 mg,5 min后可重复,直至VAS评分<4分。PACU停留观察2 h,送返病房后患者行静脉自控镇痛(PCIA)。记录VAS评分≥4分时间,第1次≥4分的VAS评分,静脉注射吗啡后VAS评分<4分所需时间,PACU中吗啡总用量,术后15 min~2 h及4、12、24、36、48 h VAS评分和PCIA吗啡用量,并观察麻醉苏醒期不良反应。结果与L组比较,S组术后VAS评分≥4分的时间延长[(33±s 8)min vs.(25±9)min,P<0.05],VAS评分<4分时间缩短[(3.7±2.8)min vs.(6±3)min,P<0.05],PACU中静脉吗啡用量减少[(9±6)mg vs.(16±9)mg,P<0.01],术后30、45、60、90、120 min的VAS评分降低(P<0.05或P<0.01)。2组不良反应发生率无显著差异(P>0.05)。结论预先注射帕瑞昔布缓解小剂量瑞芬太尼麻醉后痛觉过敏比大剂量效果更好。 AIM To investigate the influence of pretreated parecoxib on hyperalgesia after anesthesia by different doses of remifentanil.METHODS Female patients undergoing abdominal hysterectomy with general anesthesia were divided into small-dose(S group)and large-dose(L group)remifentanil group(n = 20 for each)with target plasma concentration 2 μg·L-1 and 4 μg·L-1 respectively.All patients pretreated with parecoxib 40 mg 30 min before anesthesia.Anesthesia was induced and maintained with iv infusion of remifentail at target plasma concentration 2 μg·L-1 or 4 μg·L-1 and propofol at target plasma concentration 4 mg·L-1.In post-anesthesia care unit(PACU),morphine 2 mg was given if patient's visual analogue scores(VAS)≥ 4 and it can be repeated 5 min later until VAS 4.The patients were placed in PACU for 2 h after operation and then transported to the ward using patient-controlled intravenous anagesia(PCIA)by themselves.The following events were recored:the time from the end of operation to the patient's first VAS ≥ 4,the score when the patient's first VAS ≥ 4,the time from the administration of morphine to VAS 4,the total amount of morphine consumed in PACU,the VAS scores at 15 min-2 h and 4,12,24,36,48 h after operation,the morphine consumption in PCIA,and adverse reactions.RESULTS Compared with group L,the time from the end of operation to the patient's first VAS ≥ 4 was prolonged((33 ± s 8)min vs.(25 ± 9)min,P 0.05),the time to VAS 4 was shortened((3.7 ± 2.8)min vs.(6 ± 3)min,P 0.05),the morphine consumption in PACU decreased((9 ± 6)mg vs.(16 ± 9)mg,P 0.01),and VAS scores at 30,45,60,90,120 min decreased in group S(P 0.05 or P 0.01).There was no significant difference in adverse reaction rate between the two groups(P 0.05).CONCLUSION The pretreated parecoxib to prevent hyperalgesia after anesthesia of remifentanil were more effective in small-dose remifentanil compared with large-dose remifentanil.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2010年第12期931-934,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 连云港卫生局基金资助课题(1010)
关键词 帕瑞昔布 瑞芬太尼 麻醉 子宫切除术 吗啡 痛觉过敏 parecoxib remifentanil anesthesia hysterectomy morphine hyperalgesia
  • 相关文献

参考文献6

  • 1GUNTZ E, TALLA G, ROMAN A, et al. Opioid-induced hyper- algesia[J]. Eur J Anaesthesiol. 2007, 24(2): 205-207.
  • 2TIRALLT M. DERRODE N, CLEVENOT D. et al. The effect of nefopam on morphine overconsumption induced by large-dose remifentanil during propofol anesthesia for major abdominal surgery[J]. Anesth Analg. 2006, 102(1 ) : 110-117.
  • 3JOLY V, RICHEBE P, GUIGNARD B, et al. Remifentanil- induced postoperative hyperalgesia and its prevention with small- dose ketamine[J]. Anesthesiology, 2005. 103(1 ): 147-155.
  • 4TROSTER A, SITTL R. SINCLER B, et al. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans[J]. Anesthesiology, 2006, 105(5): 1016- 1023.
  • 5魏珂,闵苏,童珊珊.帕瑞昔布防止瑞芬太尼全身麻醉苏醒期躁动及对术后镇痛的影响[J].中国新药与临床杂志,2010,29(6):441-444. 被引量:15
  • 6王庚,吴新民.瑞芬太尼复合麻醉患者术后急性阿片类药物耐受的发生[J].中华麻醉学杂志,2007,27(5):389-392. 被引量:88

二级参考文献22

  • 1吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 2KEHLET H, DAHL JB. The value of "multimodal" or "balanced analgesia" in postoperative pain treatment [J]. Anesth Analg, 1993, 77(5) : 1048-1056.
  • 3KRANKE P, MORIN AM, ROEWER N, et al. Patients global evaluation of analgesia and safety of injected parecoxib for postoperative pain:a quantitative systematic review [J]. Anesth Analg, 2004, 99(3): 797-806.
  • 4BITSCH MS, FOSS N, KRISTENSEN B, et al. Pathogenesis of and management strategies for postoperative delirium after hip fracture: a review [J]. Acta Orthop Scand, 2004, 75(4): 378- 389.
  • 5LEPOUSE C, LAUTNER CA, LIU L, et al. Emergence delirium in adults in the post-anaesthesia care unit [J]. Br J Anaesth, 2006, 96(6): 747-753.
  • 6HATZAKORZIAN R, SHAN WL, COTE AV, et al. The management of severe emergence agitation using droperidol [J]. Anesthesia, 2006, 61 ( 11 ) : 1112-1115.
  • 7Thompson JP, Rowbotham DJ. Remifentanil: an opioid for the 21st century. Br J Anaesth,1996, 76: 341-343.
  • 8Dershwitz M, Randel GI, Rosow CE, et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterase. Anesth Analg, 1995, 81: 619-623.
  • 9Yarmush J, D'Angelo R, Kirkhart B, et al. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology, 1997, 87: 235-243.
  • 10Fletcher D, Pinaud M, Scherpereel P, et al. The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg, 2000, 90: 666-671.

共引文献101

同被引文献46

  • 1丁冬,屠伟峰.老年人术后认知功能障碍的研究与防治[J].实用医学杂志,2007,23(16):2616-2618. 被引量:7
  • 2VIEL JJ, MCMANUS DQ, SMITH SS, et ol. Age-and con- centration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid[J]. Neurosci Res, 2001, 64 (5) : 44-65.
  • 3KATZ WA. Cyclooxygenase-2-selective inhibitors in the mana- gement of acute and perioperative pain[J]. Cleve Clin J Med, 2002, 69 Suppl 1 : S165- S175.
  • 4MARTIN F, FLETCHER D, CHAUVIN M, et oi. Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans [J]. Anesthesiology, 2007, 106(5): 1013-1018.
  • 5ROUZER CA, MARNETY LJ. Cyclooxygenases: structural and functional insights[J]. J Lipid Res, 2009,50 Suppl: S29-S34.
  • 6VARDEH D, WANG D, COSTIGAN M, et al. COX2 in CNS neural ceils mediates mechanical inflammatory pain hypersen- sitivity in mice[J]. J Clin Invest, 2009, 119(2): 257-294.
  • 7SWIFT JQ, GARRY MG, ROSZKOWSKI MT, et al. Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain[J]. J Oral Maxillofac Surg, 1993, 51 (2): 112-116.
  • 8JAKUBOWSKI M, LEVY D, GOOR-ARYEH I, et al. Ter- minating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors[J]. Headache, 2005, 45(7) : 850-861.
  • 9PESCE C, GRATI'AROLA M, MENINI S, et al. Cyclooxy- genase 2 expression in vessels and nerves in reversal reaction leprosy[J]. Am J Trop Med Hyg, 2006, 74(6) : 1076-1077.
  • 10CAPUANO A, de CORATO A, LISI L, et al. Proinflammatory- activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology[J]. Mol Pain, 2009, 5 : 43.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部